STOP Cancer: 8th Edition Personalized Oncology

8th Edition of the STOP Cancer

Supported by: The Association of the Transdisciplinary Society of Personalised Oncology for Combating Cancer

At the 8th Edition of the STOP Cancer: Personalised Translational Oncology conference, Dr Cristina Florescu Moraid delivered a pivotal presentation titled “Streamlining the Development of Clinical Trials Through In-Home Patient Visits.” Her insightful discussion underscored the growing significance of home visits for patients participating in clinical trials, particularly in the modern era where patient-centric care is more essential than ever.

Dr Florescu Moraid highlighted the transformative potential of decentralised clinical trials, which represent an innovative shift in how such studies are conducted. This model places the patient firmly at the heart of the research process, reorienting the traditional approach to clinical trials. By integrating in-home visits, decentralised trials create an environment that is not only convenient and supportive for patients but also conducive to fostering adherence to study protocols.

The inclusion of home visits addresses many challenges faced by patients, such as the logistical difficulties of travelling to clinical trial sites, particularly for those with limited mobility or demanding schedules. This patient-first approach not only enhances participation but also ensures that patients feel valued and cared for throughout the process. It establishes a foundation of trust, allowing individuals to engage more fully and consistently with the study’s requirements.

Dr Florescu Moraid eloquently described decentralised clinical trials as more than just a technological or logistical innovation. Instead, she framed them as an ethical realignment within the field of clinical research—a commitment to rethinking the structures that shape the patient experience. By prioritising patients’ needs and tailoring procedures to their unique circumstances, decentralised trials embody a more humane and inclusive way of advancing medical science.

Through her presentation, Dr Florescu Moraid inspired a dialogue around the broader implications of decentralisation. It is not merely about improving trial efficiency; it is a reimagining of the relationship between healthcare providers and patients, and of the systems that govern care. As she rightly pointed out, this approach heralds a future where patient empowerment and accessibility are fundamental to medical research.

This presentation served as a powerful reminder of the critical role that innovation, adaptability, and patient-centred thinking play in shaping the future of healthcare. Dr Florescu Moraid’s insights challenge the field to continue advancing these principles, ensuring that clinical trials reflect not only scientific progress but also the human values that underpin it.